Meike Hutt

4PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 19, 2026
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|May 31, 2026
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|Aug 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.

Gloria B Kim, Jens Fritsche, Sebastian Bunk

|Apr 20, 2017
Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV.

Lisa C Schmitt, Alexander Rau, Oliver Seifert

Pageof 1

Frequent Collaborators

2 joint publications

Farastuk Bozorgmehr

2 joint publications

Simon Laban

2 joint publications

Manuel Ruh

2 joint publications

Daniel Heudobler